Skip to main content

Advertisement

Log in

Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Peripheral blood mononuclear cells (PBMC) collected from subjects prior to treatment and post-treatment with a vaccine composed of leishmania antigens were analyzed by flow cytometry. Upon analysis, it was noticed that lymphocyte subsets (LS) varied with psoriasis area and severity index (PASI) range (1–10, 11–20 and 21–72). Pre-treatment absolute values of gated LS were as follows. CD4+CD8−, CD3+CD8−, CD8+CD3+, CD8+CD4− and CD8+HLA− decreased in PBMC as PASI increased, suggesting migration from the blood to the skin. Contrary to the previous finding, the following LS, CD8+HLA+ and HLA+CD8−, and membrane surface immunoglobulin IgA+, IgD+ and IgM+ increased in PBMC as PASI increased, suggesting activation and proliferation by unknown antigens. After treatment with seven doses of AS100, the following LS, CD3+CD8−, CD8+CD3−, HLA+CD8−, CD8+HLA+ and CD4+CD8−, increased, while CD8+CD3+, CD8+HLA−, CD19 and CD8+CD4+ decreased in PBMC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Abul H, Mahmoud F, Al Saleh Q et al (2002) Profiles of activated T lymphocytes in peripheral blood of Kuwaiti psoriasis vulgaris patients. J Dermatol 29:202–208

    PubMed  Google Scholar 

  2. Bachelez H (2005) Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity. J Autoimmun 25:69–73

    Article  CAS  PubMed  Google Scholar 

  3. Baker BS, Swain AF, Valdimarsson H et al (1984) T-cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol 110:37–44

    Article  CAS  PubMed  Google Scholar 

  4. Blue ML, Daley JF, Levine H et al (1985) Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 134:2281–2286

    CAS  PubMed  Google Scholar 

  5. Bock O, Kreiselmeyer I, Mrowietz U (2001) Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis. Exp Dermatol 10:414–419

    Article  CAS  PubMed  Google Scholar 

  6. Christophers E, Mrowietz U (2003) Psoriasis. In: Freedberg IM, Eisen AZ, Wolff KK, Austen F, Goldsmith LA, Si Katz (eds) Fitzpatrick’s dermatology in general medicine, 6th edn. McGraw-Hill, New York, pp 407–427

    Google Scholar 

  7. Endharti AT, Rifa’ IM, Shi Z et al (2005) Cutting Edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells. J Immunol 175:7093–7097

    CAS  PubMed  Google Scholar 

  8. Gudjonsson JE, Johnston A, Sigmundsdottir H et al (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1–8

    Article  CAS  PubMed  Google Scholar 

  9. Huang X, Yang Y (2006) The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation. Immunology 118:361–371

    Article  CAS  PubMed  Google Scholar 

  10. Kemp M, Hansen MB, Theander TG (1992) Recognition of leishmaniaantigens by T lymphocytes from nonexposed individuals. Infect Immun 60:2246–2251

    CAS  PubMed  Google Scholar 

  11. Kitchen SG, Whitmire JK, Jones NR et al (2005) The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens. Proc Natl Acad Sci USA 102:3794–3799

    Article  CAS  PubMed  Google Scholar 

  12. Koch HJ, Wollina U, Seyfarth M et al (1990) Detection of IgA in diseased skin and serum of patients with psoriasis vulgaris. Dermatol Monatsschr 176:225–231

    CAS  PubMed  Google Scholar 

  13. Krueger JG, Bowcock A (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64(Suppl 2):ii30–ii36

    Article  CAS  PubMed  Google Scholar 

  14. Langewouters AMG, van Erp PEJ, de Jong EMGJ et al (2008) Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis. Arch Dermatol Res 300:107–113

    Article  CAS  PubMed  Google Scholar 

  15. Laux I, Khoshnan A, Tindell C et al (2000) Response differences between human CD4+ and CD8+ T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin Immunol 96:187–197

    Article  CAS  PubMed  Google Scholar 

  16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193(1):265–275

    CAS  PubMed  Google Scholar 

  17. Nair RP, Ding J, Duffin KC et al (2009) Psoriasis bench to bedside. Arch Dermatol 145:462–464

    Article  PubMed  Google Scholar 

  18. Nickoloff BJ, Nestle FO (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113:1664–1675

    CAS  PubMed  Google Scholar 

  19. O’Daly JA, Lezama R, Gleason J (2009) Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis. Arch Dermatol Res 301:411–427

    Article  PubMed  Google Scholar 

  20. O’Daly JA, Lezama R, Rodriguez PJ et al (2009) Antigens from Leishmania amastigotes induced clinical remission of psoriasis. Arch Dermatol Res 301:1–13

    Article  PubMed  Google Scholar 

  21. O’Daly JA, Rodriguez MB (1988) Differential growth requirements of several leishmania spp in chemically defined culture media. Acta Trop Basel 45:109–126

    PubMed  Google Scholar 

  22. Ozturk G, Erbas D, Gelir E et al (2001) Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with psoriasis vulgaris. Immunol Invest 30:181–190

    Article  CAS  PubMed  Google Scholar 

  23. Prinz JC, Vollmer S, Boehncke WH et al (1999) Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol 29:3360–3368

    Article  CAS  PubMed  Google Scholar 

  24. Rantakokko K, Rimpilainen M, Uksila J et al (1997) Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 15:399–404

    CAS  PubMed  Google Scholar 

  25. Reibke R, Garbi N, Ganss R et al (2006) CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen. Proc Natl Acad Sci USA 103:15142–15147

    Article  CAS  PubMed  Google Scholar 

  26. Sabat R, Philipp S, Hoflich C et al (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16:779–798

    Article  CAS  PubMed  Google Scholar 

  27. Sala P, Tonutti E, Feruglio C et al (1993) Persistent expansions of CD4+ CD8+ peripheral blood T cells. Blood 82:1546–1552

    CAS  PubMed  Google Scholar 

  28. Sigmundsdottir H, Gudjonsson JE, Jonsdottir I et al (2001) The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 126:365–369

    Article  CAS  PubMed  Google Scholar 

  29. Simelyte E, Rimpilainen M, Zhang X et al (2003) Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis. Ann Rheum Dis 62:976–982

    Article  CAS  PubMed  Google Scholar 

  30. Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85

    Article  CAS  PubMed  Google Scholar 

  31. Trautmann A, Rückert B, Schmid-Grendelmeier P (2003) Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation. Immunology 108:305–312

    Article  CAS  PubMed  Google Scholar 

  32. Van Lingen RG, van de Kerkhof PCM, de Jong EMGJ et al (2008) Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients. Exp Dermatol 17:343–348

    Article  PubMed  Google Scholar 

  33. Wu Y, Zheng Z, Jiang Y et al (2009) The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci USA 106:534–539

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Jose Godoy for critical discussions, reading the text many times, suggesting useful ideas and his excellent help as medical writer. Jose A. O’Daly, Astralis CSO, CEO and Chairman, would also like to thank The Technology Business Tax Certificate Transfer Program of the Greater State of New Jersey, Economic Development Authority (eda) and to the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICIT) for its support, under contract # RP-IV-120030, while Dr. O’Daly was in Caracas, Venezuela.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose Antonio O’Daly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Daly, J.A., Rodriguez, B., Ovalles, T. et al. Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens. Arch Dermatol Res 302, 95–104 (2010). https://doi.org/10.1007/s00403-009-0992-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-009-0992-0

Keywords

Navigation